Literature DB >> 12570779

Application of NMR screening in drug discovery.

Jasna Fejzo1, Christopher Lepre, Xiaoling Xie.   

Abstract

The application of NMR screening in drug discovery has recently attained heightened importance throughout the pharmaceutical industry. NMR screening can be applied at various points in a drug discovery program, ranging from very early in the program, when new targets can be screened long before an HTS enzymatic assay is developed, to later in the program, as in the case where no useful hits have been detected by HTS using biological assays. The binders determined in primary NMR screens are used to guide secondary screens, which can be either completely NMR driven or use NMR in combination with other biophysical techniques. In this review we briefly discuss the methods and techniques used in NMR screening. Then, we describe in detail the NMR screening strategies and their applications to specific targets, including successful examples from actual drug design programs at our own and other pharmaceutical companies.

Mesh:

Substances:

Year:  2003        PMID: 12570779     DOI: 10.2174/1568026033392796

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  5 in total

1.  A universal method for fishing target proteins from mixtures of biomolecules using isothermal titration calorimetry.

Authors:  Xingding Zhou; Qingxiang Sun; R Manjunatha Kini; J Sivaraman
Journal:  Protein Sci       Date:  2008-07-11       Impact factor: 6.725

2.  Application of isothermal titration calorimetry and column chromatography for identification of biomolecular targets.

Authors:  Xingding Zhou; R Manjunatha Kini; J Sivaraman
Journal:  Nat Protoc       Date:  2011-01-20       Impact factor: 13.491

3.  Estimating protein-ligand binding affinity using high-throughput screening by NMR.

Authors:  Matthew D Shortridge; David S Hage; Gerard S Harbison; Robert Powers
Journal:  J Comb Chem       Date:  2008-10-03

Review 4.  Solution NMR Spectroscopy in Target-Based Drug Discovery.

Authors:  Yan Li; Congbao Kang
Journal:  Molecules       Date:  2017-08-23       Impact factor: 4.411

5.  Overcoming the limitations of fragment merging: rescuing a strained merged fragment series targeting Mycobacterium tuberculosis CYP121.

Authors:  Sean A Hudson; Sachin Surade; Anthony G Coyne; Kirsty J McLean; David Leys; Andrew W Munro; Chris Abell
Journal:  ChemMedChem       Date:  2013-06-20       Impact factor: 3.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.